NormOxys News
Most Popular NormOxys Story
NormOxys gets $17.5M to fund PoC work on new drug class
Wellesley, MA-based NormOxys has wrapped a $17.5 million Series B round, which the developer says should be enough to cover the tab for its crucial proof-of-concept work. About a year from now the Read more...
Latest Headlines
- December 4, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
